Ivonescimab Scores Landmark Phase III Win in Biliary Tract Cancer, Solidifying Summit and Akeso’s High-Stakes Bet
Executive Overview The landscape of modern immuno-oncology is shifting once again, driven by a novel class of bispecific antibodies designed...
